Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients

The phenotype of circulating tumor cells (CTCs) is supposed to be significant indicator that is correlated the prognosis of breast cancer patients who have completed neoadjuvant chemotherapy, primary tumor surgery with/without adjuvant chemotherapy. The aim of this observational study is to assess the efficacy of CTCs surveillance in predicting the prognosis of breast cancer patients.

NCT Number	NCT05326295
Lead Sponsor	Hunan Cancer Hospital
Conditions	Breast Neoplasms, Neoplastic Cells, Circulating, Chemotherapy Effect
Enrollment	1,000 participants
Start Date	2019-03-01
Primary Completion	2028-03-01 (estimated)
Study Completion	2029-03-01 (estimated)
Updated on ClinicalTrials.gov	2022-04-13